Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

Andrew H. Wei; Panayiotis Panayiotidis; Pau Montesinos; Kamel Laribi; Vladimir Ivanov; Inho Kim; Jan Novak; Rebecca Champion; Walter Fiedler; Maria Pagoni; Julie Bergeron; Stephen B. Ting; Jing Zhou Hou; Achilles Anagnostopoulos; Andrew McDonald; Vidhya Murthy; Takahiro Yamauchi; Jianxiang Wang; Qi Jiang; Yan Sun; Brenda Chyla; Wellington Mendes; Courtney D. DiNardo

doi:10.1182/blood.2022016963

Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

Andrew H. Wei, Panayiotis Panayiotidis, Pau Montesinos, Kamel Laribi, Vladimir Ivanov, Inho Kim, Jan Novak, Rebecca Champion, Walter Fiedler, Maria Pagoni, Julie Bergeron, Stephen B. Ting, Jing Zhou Hou, Achilles Anagnostopoulos, Andrew McDonald, Vidhya Murthy, Takahiro Yamauchi, Jianxiang Wang, Qi Jiang, Yan SunBrenda Chyla, Wellington Mendes, Courtney D. DiNardo

Leukemia

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Original language	English (US)
Pages (from-to)	2754-2756
Number of pages	3
Journal	Blood
Volume	140
Issue number	25
DOIs	https://doi.org/10.1182/blood.2022016963
State	Published - Dec 22 2022

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2022016963

Cite this

Wei, A. H., Panayiotidis, P., Montesinos, P., Laribi, K., Ivanov, V., Kim, I., Novak, J., Champion, R., Fiedler, W., Pagoni, M., Bergeron, J., Ting, S. B., Hou, J. Z., Anagnostopoulos, A., McDonald, A., Murthy, V., Yamauchi, T., Wang, J., Jiang, Q., ... DiNardo, C. D. (2022). Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy. Blood, 140(25), 2754-2756. https://doi.org/10.1182/blood.2022016963

Wei, AH, Panayiotidis, P, Montesinos, P, Laribi, K, Ivanov, V, Kim, I, Novak, J, Champion, R, Fiedler, W, Pagoni, M, Bergeron, J, Ting, SB, Hou, JZ, Anagnostopoulos, A, McDonald, A, Murthy, V, Yamauchi, T, Wang, J, Jiang, Q, Sun, Y, Chyla, B, Mendes, W & DiNardo, CD 2022, 'Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy', Blood, vol. 140, no. 25, pp. 2754-2756. https://doi.org/10.1182/blood.2022016963

@article{9194057b6da94b3da585b6fe9a674353,

title = "Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy",

author = "Wei, {Andrew H.} and Panayiotis Panayiotidis and Pau Montesinos and Kamel Laribi and Vladimir Ivanov and Inho Kim and Jan Novak and Rebecca Champion and Walter Fiedler and Maria Pagoni and Julie Bergeron and Ting, {Stephen B.} and Hou, {Jing Zhou} and Achilles Anagnostopoulos and Andrew McDonald and Vidhya Murthy and Takahiro Yamauchi and Jianxiang Wang and Qi Jiang and Yan Sun and Brenda Chyla and Wellington Mendes and DiNardo, {Courtney D.}",

note = "Funding Information: AbbVie and the authors thank all the trial investigators and patients who participated in this clinical trial. Medical writing support was provided by Susan Olalekan of AbbVie, Inc. Editorial support was provided by Angela T. Hadsell of AbbVie, Inc. Contribution: All authors contributed to provision, collection, and assembly of data; A.H.W. Q.J. Y.S. B.C. and W.M. contributed in data analysis and interpretation; all authors contributed thereafter in manuscript writing, critical revision, and approved the final version for submission. AbbVie, Inc contributed to the study conception and design.",

year = "2022",

month = dec,

day = "22",

doi = "10.1182/blood.2022016963",

language = "English (US)",

volume = "140",

pages = "2754--2756",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "25",

}

TY - JOUR

T1 - Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

AU - Wei, Andrew H.

AU - Panayiotidis, Panayiotis

AU - Montesinos, Pau

AU - Laribi, Kamel

AU - Ivanov, Vladimir

AU - Kim, Inho

AU - Novak, Jan

AU - Champion, Rebecca

AU - Fiedler, Walter

AU - Pagoni, Maria

AU - Bergeron, Julie

AU - Ting, Stephen B.

AU - Hou, Jing Zhou

AU - Anagnostopoulos, Achilles

AU - McDonald, Andrew

AU - Murthy, Vidhya

AU - Yamauchi, Takahiro

AU - Wang, Jianxiang

AU - Jiang, Qi

AU - Sun, Yan

AU - Chyla, Brenda

AU - Mendes, Wellington

AU - DiNardo, Courtney D.

N1 - Funding Information: AbbVie and the authors thank all the trial investigators and patients who participated in this clinical trial. Medical writing support was provided by Susan Olalekan of AbbVie, Inc. Editorial support was provided by Angela T. Hadsell of AbbVie, Inc. Contribution: All authors contributed to provision, collection, and assembly of data; A.H.W. Q.J. Y.S. B.C. and W.M. contributed in data analysis and interpretation; all authors contributed thereafter in manuscript writing, critical revision, and approved the final version for submission. AbbVie, Inc contributed to the study conception and design.

PY - 2022/12/22

Y1 - 2022/12/22

UR - http://www.scopus.com/inward/record.url?scp=85142159148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85142159148&partnerID=8YFLogxK

U2 - 10.1182/blood.2022016963

DO - 10.1182/blood.2022016963

M3 - Article

C2 - 36112968

AN - SCOPUS:85142159148

SN - 0006-4971

VL - 140

SP - 2754

EP - 2756

JO - Blood

JF - Blood

IS - 25

ER -

Long-term follow-up of VIALE-C in patients with untreated AML ineligible for intensive chemotherapy

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this